pre-IPO PHARMA

ironshore-pharmaceuticals PRESS RELEASE ARCHIVE

Jan 6, 2020

Ironshore Pharmaceuticals Hires New Chief Financial Officer and Appoints a Chief Commercial Officer


Nov 5, 2019

Ironshore Pharmaceuticals Partners With Verix to Support Launch of Prescription Medication USA - English USA - English


Oct 28, 2019

Ironshore Pharmaceuticals Recognizes ADHD Awareness Month Through Partnership With CHADD


Oct 16, 2019

Ironshore Pharmaceuticals to Present Data at the 66th Annual AACAP Meeting


May 17, 2019

Ironshore Pharmaceuticals to Showcase JORNAY PM™ (Methylphenidate HCl) CII at the 2019 American Psychiatric Association Meeting



Jan 17, 2019

Ironshore Pharmaceuticals Announces Appointment of Dr. Lewis Warrington as Vice President / Head of Medical Affairs


Sep 6, 2018

Ironshore Pharmaceuticals Announces Appointment of W. Scott Evangelista as President and Chief Operating Officer


Aug 14, 2018

Ironshore Pharmaceuticals Announces Agreement for $143 Million in Senior Secured Notes Financing


Aug 9, 2018

Ironshore Pharmaceuticals Announces FDA Approval of JORNAY PMTM (Methylphenidate) Extended-Release Capsules CII for the Treatment of ADHD


Jul 12, 2018

Ironshore Pharmaceuticals Announces PDUFA Date of August 8, 2018 for HLD200



Oct 25, 2017

Ironshore Pharmaceuticals Presents Data from Pivotal Trial at AACAP’S Annual Meeting


Jun 6, 2017

Ironshore Pharmaceuticals Announces Appointment of Seasoned Experts to Its Expanding Executive Team


May 23, 2017

Ironshore Pharmaceuticals Presents Pivotal Trial Data at American Psychiatric Association Meeting


Apr 19, 2017

Ironshore Pharmaceuticals to Present Data at the 6th World Congress on ADHD


Jan 24, 2017

Ironshore Pharmaceuticals Announces Closing of $200 Million Financing



Dec 15, 2016

Ironshore Pharmaceuticals Announces FDA Acceptance of HLD200 New Drug Application for Treatment of ADHD


Oct 28, 2016

Ironshore Pharmaceuticals Presents New Pivotal Trial Data at AACAP Meeting


Oct 21, 2016

Ironshore Pharmaceuticals to Present Data at Scientific Meetings


Oct 5, 2016

Ironshore Pharmaceuticals and CHADD to Raise Awareness about the Negative Impact of ADHD During the Early Morning Routine


Google Analytics Alternative